5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)

Bibliographic Details
Main Authors: P. Bartolucci, K.I. Ataga, M. Callaghan, L. De Franceschi, C. Minniti, A. Alexandrou, D.-.C. Imbs, R.P. Fox, H. Patel, A. Sostelly, J. Schimmel
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000928292.81037.b2
_version_ 1797279709554278400
author P. Bartolucci
K.I. Ataga
M. Callaghan
L. De Franceschi
C. Minniti
A. Alexandrou
D.-.C. Imbs
R.P. Fox
H. Patel
A. Sostelly
J. Schimmel
author_facet P. Bartolucci
K.I. Ataga
M. Callaghan
L. De Franceschi
C. Minniti
A. Alexandrou
D.-.C. Imbs
R.P. Fox
H. Patel
A. Sostelly
J. Schimmel
author_sort P. Bartolucci
collection DOAJ
first_indexed 2024-03-07T16:30:52Z
format Article
id doaj.art-caf22b796a8b4e06b2960cf7684fe49f
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:30:52Z
publishDate 2023-04-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-caf22b796a8b4e06b2960cf7684fe49f2024-03-03T11:20:30ZengWileyHemaSphere2572-92412023-04-017S1222210.1097/01.HS9.0000928292.81037.b2202304001-000415610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)P. BartolucciK.I. AtagaM. CallaghanL. De FranceschiC. MinnitiA. AlexandrouD.-.C. ImbsR.P. FoxH. PatelA. SostellyJ. Schimmelhttp://journals.lww.com/10.1097/01.HS9.0000928292.81037.b2
spellingShingle P. Bartolucci
K.I. Ataga
M. Callaghan
L. De Franceschi
C. Minniti
A. Alexandrou
D.-.C. Imbs
R.P. Fox
H. Patel
A. Sostelly
J. Schimmel
5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
HemaSphere
title 5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_full 5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_fullStr 5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_full_unstemmed 5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_short 5610823 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
title_sort 5610823 trial in progress the randomized double blind placebo controlled phase 1b crosswalk a trial evaluating the safety of crovalimab for the management of acute uncomplicated vaso occlusive episodes voes in patients pts with sickle cell disease scd
url http://journals.lww.com/10.1097/01.HS9.0000928292.81037.b2
work_keys_str_mv AT pbartolucci 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT kiataga 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT mcallaghan 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT ldefranceschi 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT cminniti 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT aalexandrou 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT dcimbs 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT rpfox 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT hpatel 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT asostelly 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd
AT jschimmel 5610823trialinprogresstherandomizeddoubleblindplacebocontrolledphase1bcrosswalkatrialevaluatingthesafetyofcrovalimabforthemanagementofacuteuncomplicatedvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd